UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000027899
Receipt No. R000031937
Official scientific title of the study Investigation for safety and efficacy of a new antiseptic Olanexidine Gluconate in children
Date of disclosure of the study information 2017/06/25
Last modified on 2018/09/18 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Investigation for safety and efficacy of a new antiseptic Olanexidine Gluconate in children
Title of the study (Brief title) Investigation for safety and efficacy of a new antiseptic Olanexidine Gluconate in children
Region
Japan

Condition
Condition Patients who undergo surgery of catheter insertion or inguinal hernia
Classification by specialty
Surgery in general Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study was designed to measure the safety and the efficacy of a new antiseptic Olanexidine gluconate in children.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Primary outcome was determined to assess the rate of any adverse effect such as labo data, vital sign, subjective and objective symptom, erythema or irritation of the skin.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 An applicator of 1.5% Olamexidine gluconate is used at surgical site.
The skin site exposed to 1.5% Olamexidine gluconate are inspected daily by the bed side nursse or physician to assess any adverse effect such as labo data, vital sign, subjective and objective symptom, erythema or irritation of the skin.
Blood concentration of 1.5% Olamexidine gluconate was measured at 0, 2, 24 hours after surgery to draw AUC curve in patients with catheter insertion.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
16 years-old >
Gender Male and Female
Key inclusion criteria (1)Children who undergo surgery for catheter insertion or inguinal hernia from 1 to 16 years
of age.
(2)No abnormal appearance of the skin for surgical incision.
(3)Informed concent was obtained from guardians.
Key exclusion criteria (1)History of drug sensitivity.
(2)History of shock or hypersensitivity against Chlorhexidine gluconate.
(3)Patients having cutaneous disease
(4)Any patients who was judged as inappropriate candidate to enroll this study
Target sample size 55

Research contact person
Name of lead principal investigator Toshihiko Watanabe
Organization National Center for Child Health and Development
Division name Division of Surgery
Address 2-10-1 Okura,Setagaya-ku, Tokyo 157-8535
TEL 03-3416-0181
Email watanabe-ts@ncchd.go.jp

Public contact
Name of contact person Kyoko Hagino
Organization National Center for Child Health and Development
Division name Division of Medical Research
Address 2-10-1 Okura,Setagaya-ku, Tokyo 157-8535
TEL 03-3416-0181
Homepage URL
Email hagino-k@ncchd.go.jp

Sponsor
Institute National Center for Child Health and Development
Institute
Department

Funding Source
Organization Otsuka Pharmaceutical Factory Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 25 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 11 Month 30 Day
Anticipated trial start date
2017 Year 06 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 06 Month 23 Day
Last modified on
2018 Year 09 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031937